Enhanced sympathetic signaling, often associated with obesity and chronic stress, is
increasingly acknowledged as a contributor to cancer aggressiveness. In prostate cancer …

Cancer research relies heavily on murine models for evaluating the anti-tumour efficacy of
therapies. Here we show that the sensitivity of several pancreatic tumour models to cytotoxic …

The serendipitous demonstration that the nonselective β‐adrenergic receptor (β‐AR)
antagonist propranolol promotes the regression of infantile hemangiomas (IHs) aroused …

Colon cancer is the fourth and third most common cancer, respectively in men and women
worldwide and its incidence is on the increase. Stress response has been associated with …

Graft-versus-host disease (GVHD) is the major complication of allogeneic hematopoietic cell
transplantation, a potentially curative therapy for hematologic diseases. It has long been …

The potential for immune cells to control cancers has been recognized for many decades,
but only recently has real excitement begun to spread through the oncology community …

The tumor microenvironment is known to play a pivotal role in driving cancer progression
and governing response to therapy. This is of significance in pancreatic cancer where the …

Lifestyle modification pivoting on nutritional management holds tremendous potential to
meet the challenge of management of diabetes. The current study hypothesizes that regular …

The production of new blood cells relies on a hierarchical network of hematopoietic stem
and progenitor cells (HSPCs). To maintain lifelong hematopoiesis, HSPCs must be …

Human angiosarcomas and canine hemangiosarcomas are highly aggressive cancers
thought to arise from cells of vascular origin. The pathological features, morphological …